United States Peptide Nucleic Acids Market Report 2016

United States Peptide Nucleic Acids Market Report 2016

1 Peptide Nucleic Acids Overview

1.1 Product Overview and Scope of Peptide Nucleic Acids

1.2 Classification of Peptide Nucleic Acids

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Peptide Nucleic Acids

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Peptide Nucleic Acids (2011-2021)

1.4.1 United States Peptide Nucleic Acids Sales and Growth Rate (2011-2021)

1.4.2 United States Peptide Nucleic Acids Revenue and Growth Rate (2011-2021)

2 United States Peptide Nucleic Acids Competition by Manufacturers

2.1 United States Peptide Nucleic Acids Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Peptide Nucleic Acids Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Peptide Nucleic Acids Average Price by Manufactures (2015 and 2016)

2.4 Peptide Nucleic Acids Market Competitive Situation and Trends

2.4.1 Peptide Nucleic Acids Market Concentration Rate

2.4.2 Peptide Nucleic Acids Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Peptide Nucleic Acids Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Peptide Nucleic Acids Sales and Market Share by Type (2011-2016)

3.2 United States Peptide Nucleic Acids Revenue and Market Share by Type (2011-2016)

3.3 United States Peptide Nucleic Acids Price by Type (2011-2016)

3.4 United States Peptide Nucleic Acids Sales Growth Rate by Type (2011-2016)

4 United States Peptide Nucleic Acids Sales (Volume) by Application (2011-2016)

4.1 United States Peptide Nucleic Acids Sales and Market Share by Application (2011-2016)

4.2 United States Peptide Nucleic Acids Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Peptide Nucleic Acids Manufacturers Profiles/Analysis

5.1 Abbott Molecular Inc. (US)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Peptide Nucleic Acids Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Abbott Molecular Inc. (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Life Technologies Corporation (US)

5.2.2 Peptide Nucleic Acids Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Life Technologies Corporation (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Affymetrix, Inc. (US)

5.3.2 Peptide Nucleic Acids Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Affymetrix, Inc. (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 PerkinElmer, Inc. (US)

5.4.2 Peptide Nucleic Acids Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 PerkinElmer, Inc. (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Bluegnome, ltd. (UK)

5.5.2 Peptide Nucleic Acids Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Bluegnome, ltd. (UK) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Applied Spectral Imaging (US)

5.6.2 Peptide Nucleic Acids Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Applied Spectral Imaging (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 SciGene Corporation (US)

5.7.2 Peptide Nucleic Acids Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 SciGene Corporation (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 BI Biological Industries (Israel)

5.8.2 Peptide Nucleic Acids Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 BI Biological Industries (Israel) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 ChromTrax (US)

5.9.2 Peptide Nucleic Acids Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 ChromTrax (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 CytoTest, Inc. (UK)

5.10.2 Peptide Nucleic Acids Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 CytoTest, Inc. (UK) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Cytognomix, Inc. (Canada)

5.12 Illumina, Inc. (US)

5.13 Inter Medico (Canada)

5.14 Kreatech Diagnostics (The Netherlands)

5.15 Oxford Gene Technology (UK)

5.16 Roche NimbleGen, Inc. (US)

6 Peptide Nucleic Acids Manufacturing Cost Analysis

6.1 Peptide Nucleic Acids Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Peptide Nucleic Acids

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Peptide Nucleic Acids Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Peptide Nucleic Acids Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Peptide Nucleic Acids Market Forecast (2016-2021)

10.1 United States Peptide Nucleic Acids Sales, Revenue Forecast (2016-2021)

10.2 United States Peptide Nucleic Acids Sales Forecast by Type (2016-2021)

10.3 United States Peptide Nucleic Acids Sales Forecast by Application (2016-2021)

10.4 Peptide Nucleic Acids Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Peptide Nucleic Acids

Table Classification of Peptide Nucleic Acids

Figure United States Sales Market Share of Peptide Nucleic Acids by Type in 2015

Table Application of Peptide Nucleic Acids

Figure United States Sales Market Share of Peptide Nucleic Acids by Application in 2015

Figure United States Peptide Nucleic Acids Sales and Growth Rate (2011-2021)

Figure United States Peptide Nucleic Acids Revenue and Growth Rate (2011-2021)

Table United States Peptide Nucleic Acids Sales of Key Manufacturers (2015 and 2016)

Table United States Peptide Nucleic Acids Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Peptide Nucleic Acids Sales Share by Manufacturers

Figure 2016 Peptide Nucleic Acids Sales Share by Manufacturers

Table United States Peptide Nucleic Acids Revenue by Manufacturers (2015 and 2016)

Table United States Peptide Nucleic Acids Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Peptide Nucleic Acids Revenue Share by Manufacturers

Table 2016 United States Peptide Nucleic Acids Revenue Share by Manufacturers

Table United States Market Peptide Nucleic Acids Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Peptide Nucleic Acids Average Price of Key Manufacturers in 2015

Figure Peptide Nucleic Acids Market Share of Top 3 Manufacturers

Figure Peptide Nucleic Acids Market Share of Top 5 Manufacturers

Table United States Peptide Nucleic Acids Sales by Type (2011-2016)

Table United States Peptide Nucleic Acids Sales Share by Type (2011-2016)

Figure United States Peptide Nucleic Acids Sales Market Share by Type in 2015

Table United States Peptide Nucleic Acids Revenue and Market Share by Type (2011-2016)

Table United States Peptide Nucleic Acids Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Peptide Nucleic Acids by Type (2011-2016)

Table United States Peptide Nucleic Acids Price by Type (2011-2016)

Figure United States Peptide Nucleic Acids Sales Growth Rate by Type (2011-2016)

Table United States Peptide Nucleic Acids Sales by Application (2011-2016)

Table United States Peptide Nucleic Acids Sales Market Share by Application (2011-2016)

Figure United States Peptide Nucleic Acids Sales Market Share by Application in 2015

Table United States Peptide Nucleic Acids Sales Growth Rate by Application (2011-2016)

Figure United States Peptide Nucleic Acids Sales Growth Rate by Application (2011-2016)

Table Abbott Molecular Inc. (US) Basic Information List

Table Abbott Molecular Inc. (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Molecular Inc. (US) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Life Technologies Corporation (US) Basic Information List

Table Life Technologies Corporation (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Life Technologies Corporation (US) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Affymetrix, Inc. (US) Basic Information List

Table Affymetrix, Inc. (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Affymetrix, Inc. (US) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table PerkinElmer, Inc. (US) Basic Information List

Table PerkinElmer, Inc. (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table PerkinElmer, Inc. (US) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Bluegnome, ltd. (UK) Basic Information List

Table Bluegnome, ltd. (UK) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bluegnome, ltd. (UK) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Applied Spectral Imaging (US) Basic Information List

Table Applied Spectral Imaging (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Applied Spectral Imaging (US) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table SciGene Corporation (US) Basic Information List

Table SciGene Corporation (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table SciGene Corporation (US) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table BI Biological Industries (Israel) Basic Information List

Table BI Biological Industries (Israel) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table BI Biological Industries (Israel) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table ChromTrax (US) Basic Information List

Table ChromTrax (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table ChromTrax (US) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table CytoTest, Inc. (UK) Basic Information List

Table CytoTest, Inc. (UK) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table CytoTest, Inc. (UK) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Cytognomix, Inc. (Canada) Basic Information List

Table Cytognomix, Inc. (Canada) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cytognomix, Inc. (Canada) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Illumina, Inc. (US) Basic Information List

Table Illumina, Inc. (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Illumina, Inc. (US) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Inter Medico (Canada) Basic Information List

Table Inter Medico (Canada) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Inter Medico (Canada) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Kreatech Diagnostics (The Netherlands) Basic Information List

Table Kreatech Diagnostics (The Netherlands) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kreatech Diagnostics (The Netherlands) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Oxford Gene Technology (UK) Basic Information List

Table Oxford Gene Technology (UK) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Oxford Gene Technology (UK) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Roche NimbleGen, Inc. (US) Basic Information List

Table Roche NimbleGen, Inc. (US) Peptide Nucleic Acids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche NimbleGen, Inc. (US) Peptide Nucleic Acids Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Peptide Nucleic Acids

Figure Manufacturing Process Analysis of Peptide Nucleic Acids

Figure Peptide Nucleic Acids Industrial Chain Analysis

Table Raw Materials Sources of Peptide Nucleic Acids Major Manufacturers in 2015

Table Major Buyers of Peptide Nucleic Acids

Table Distributors/Traders List

Figure United States Peptide Nucleic Acids Production and Growth Rate Forecast (2016-2021)

Figure United States Peptide Nucleic Acids Revenue and Growth Rate Forecast (2016-2021)

Table United States Peptide Nucleic Acids Production Forecast by Type (2016-2021)

Table United States Peptide Nucleic Acids Consumption Forecast by Application (2016-2021)